drug
Fensolvi
Marketedupdated 3mo agoby Tolmar Pharmaceuticals Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7- tagApproval258 co-mentions · 123 sources
- drugLEUPROLIDE ACETATE216 co-mentions · 123 sources
- drugleuprolide acetate PR170 co-mentions · 123 sources
- drugFENSOLVI KIT141 co-mentions · 123 sources
- drugleuprolide acetate ER129 co-mentions · 123 sources
- drugleuprolide acetate SR129 co-mentions · 123 sources
- tagEndocrinology & Metabolism75 co-mentions · 75 sources
all catalysts(0)
nothing on the calendar yet
Trials studying Fensolvi
- phase2A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
- phase1Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer
- phase2Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
- phase2Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
- phase1Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
- phase2Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma
- phase3Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate
- phase2Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 28m ago
Found something off?
comments(0)
5-min edit window · permanent after that